It’s lucky number seven for Medable. The decentralized clinical trials technology company has hired MaryAnne Rizk, Ph.D., as chief strategy officer to lead global partnerships in a year filled with executive hires.
Medable has stacked its leadership team with more than $200 million raised in the past year. The tech company has hired at least seven C-suite executives this year alone, including chiefs across science, growth, product, design, operations and HR. Rizk is number seven.
That number doesn’t include the half-dozen or so vice presidents hired this year.
Rizk joins Medable after leading the digital R&D cloud strategy at IQVIA for two years. Prior to that, Rizk was global vice president of CRO partnerships for Oracle for five years and previously was a director at Medidata Solutions and a project manager at Merck.
The new C-suite hire will focus on forming global partnerships with CROs along with medical device, software and data companies, Medable said Tuesday. Rizk is tasked with increasing Medable’s patient-centered focus through collaborations that boost diverse patient recruitment and retention through decentralized clinical trials.